Page last updated: 2024-11-02

pd 98059 and Cranial Nerve II Injuries

pd 98059 has been researched along with Cranial Nerve II Injuries in 2 studies

2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one: inhibits MAP kinase kinase (MEK) activity, p42 MAPK and p44 MAPK; structure in first source
2-(2-amino-3-methoxyphenyl)chromen-4-one : A member of the class of monomethoxyflavones that is 3'-methoxyflavone bearing an additional amino substituent at position 2'.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Park, K1
Luo, JM2
Hisheh, S1
Harvey, AR1
Cui, Q2
Cen, LP1
Zhang, XM1
Chiang, SW1
Huang, Y1
Lin, D1
Fan, YM1
van Rooijen, N1
Lam, DS1
Pang, CP1

Other Studies

2 other studies available for pd 98059 and Cranial Nerve II Injuries

ArticleYear
Cellular mechanisms associated with spontaneous and ciliary neurotrophic factor-cAMP-induced survival and axonal regeneration of adult retinal ganglion cells.
    The Journal of neuroscience : the official journal of the Society for Neuroscience, 2004, Dec-01, Volume: 24, Issue:48

    Topics: Animals; Axons; Carbazoles; Cell Survival; Chromones; Ciliary Neurotrophic Factor; Cyclic AMP; Cycli

2004
PI3K/akt, JAK/STAT and MEK/ERK pathway inhibition protects retinal ganglion cells via different mechanisms after optic nerve injury.
    The European journal of neuroscience, 2007, Volume: 26, Issue:4

    Topics: Analgesics, Non-Narcotic; Animals; Axons; Axotomy; Blotting, Western; Butadienes; Chromones; Clodron

2007